Hirsch et al. 16 demonstrated that 28-8, 22C3 and SP263 were highly consistent in evaluating the PD-L1 expression on tumor cells, while the positive rate of SP142 antibody was lower compared with the other three assays. Here, CD274 is linked to neoplasm.